As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sa ...
With rising cases of COVID-19 new Omicron variant in the country, the top health experts are emphasizing accelerating genome sequencing to detect Omicron variant. ...